These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6773541)

  • 21. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Sane DC; Hutson SM
    Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural prenylquinones inhibit the enzymes of the vitamin K cycle in vitro.
    Ronden JE; Soute BA; Thijssen HH; Saupe J; Vermeer C
    Biochim Biophys Acta; 1996 Nov; 1298(1):87-94. PubMed ID: 8948492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The function and metabolism of vitamin K.
    Olson RE
    Annu Rev Nutr; 1984; 4():281-337. PubMed ID: 6380538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
    Vermeer C; Soute BA; De Metz M; Hemker HC
    Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic functions and mechanism of action of vitamin K.
    Uotila L
    Scand J Clin Lab Invest Suppl; 1990; 201():109-17. PubMed ID: 2244179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
    Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profactor IX propeptide and glutamate substrate binding sites on the vitamin K-dependent carboxylase identified by site-directed mutagenesis.
    Sugiura I; Furie B; Walsh CT; Furie BC
    J Biol Chem; 1996 Jul; 271(30):17837-44. PubMed ID: 8663364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
    Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Hutson SM
    Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification.
    Bandyopadhyay PK
    Vitam Horm; 2008; 78():157-84. PubMed ID: 18374194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.